MR 409
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-P3304-1MG | 1 mg | 751,00 | Add | |
| HY-P3304-5MG | 5 mg | 1'634,00 | Add | |
| HY-P3304-10MG | 10 mg | 2'610,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
MR 409 is a selected growth hormone-releasing hormone (GHRH) agonist. MR 409 has remarkable neuroprotective effects through enhancing endogenous neurogenesis in cerebral ischemic mice. MR 409 also inhibits the in vivo growth of lung cancer[1][2][3][4].
| Category | Peptide |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Neurological Disease, s |
| Format | Solubility: 10 mM in DMSO |
| Grade | Clinical information: No Development Reported |
| Purity | 99.9% |
| Molecular Formula | C153H252N44O43 |
| Molecular Weight | 3395.91 |
| CAS-Number | 1445155-39-4 |
| Storage Conditions | -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Blue Ice |
| Material Safety Data Sheet | Download PDF |
